Prescribing decisions are currently guided primarily by therapeutic efficacy, patient safety and cost-effectiveness. A recent feasibility study explores how environmental information could also become part of routine pharmaceutical decision-making in the future. At the centre of the proposed concept is a German Environmental Pharmaceutical Index (EPI), designed to provide standardised environmental information on active pharmaceutical ingredients (APIs) and make it readily accessible for healthcare professionals.

Although pharmaceuticals are indispensable for public healthcare, their environmental impacts are rarely considered during prescribing or dispensing. A newly developed Environmental Pharmaceutical Index (EPI) aims to integrate environmental information systematically into pharmaceutical and medical decision-making. The objective is to balance therapeutical needs and environmental impacts by supporting the selection of therapeutically equivalent medicines with lower environmental impacts without compromising patient care.

The research project “Feasibility Study on the Establishment of an Environmental Information and Classification System for Pharmaceuticals in Germany”, led by Ecologic Institute, developed a concept for an environmental information and classification system for Germany and conducted a feasibility analysis for this concept, evaluating organizational, technical, legal, financial and political feasibility. The project results were presented to a wide range of interested parties at a final presentation held at the beginning of March 2025. Over 110 participants, including representatives from the pharmaceutical industry, health insurance companies, doctors, pharmacists and environmental authorities, took part in the online event.

The goal of the research project is a feasibility study on the introduction of environmental information and classification system for pharmaceuticals in Germany. The results of this feasibility study will include not only an assessment of the organizational or legal viability but also the development of a comprehensive concept for the successful integration into the daily professional practices of doctors and pharmacists in Germany.